{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T13:51:04Z","timestamp":1783086664340,"version":"3.54.6"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,2,8]],"date-time":"2022-02-08T00:00:00Z","timestamp":1644278400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,2,8]],"date-time":"2022-02-08T00:00:00Z","timestamp":1644278400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82071505"],"award-info":[{"award-number":["82071505"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81825009"],"award-info":[{"award-number":["81825009"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81901358"],"award-info":[{"award-number":["81901358"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81221002"],"award-info":[{"award-number":["81221002"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Transl Psychiatry"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>QTc interval prolongation is one of the most common antipsychotic-induced side effects which could lead to ventricular tachycardia or Torsade de Pointes, even cardiac arrest. There is very limited understanding on the genetic factors that associated with antipsychotic-induced QTc interval change. We conducted a genome-wide association study (GWAS) of antipsychotic-induced QTc interval change among patients with schizophrenia. A total of 2040 patients with schizophrenia were randomly assigned to six groups (olanzapine, risperidone, quetiapine, aripiprazole, ziprasidone, and first-generation antipsychotics; first-generation antipsychotics including haloperidol or perphenazine were also assigned randomly) and received 6-week antipsychotic treatment. We identified two novel loci (rs200050752 in <jats:italic>ATAD3B<\/jats:italic> and rs186507741 in <jats:italic>SKIL<\/jats:italic>) that were associated with antipsychotic-induced QTc interval change at a genome-wide significance level. The combination of polygenic risk score (PRS), based the GWAS of myocardial infarction from BioBank Japan project, and clinical data (sex, heart rate and QTc interval at baseline) could be applied to predict whether patients with schizophrenia have QTc interval prolongation (10\u2009ms was applied as threshold, <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001, area under the curve [AUC] was 0.797), especially for the first episode patients (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001, AUC was 0.872). We identified two loci located within genes related to mitochondrial function and cell growth and differentiation, which were both associated with schizophrenia and heart function. The combination of PRS and clinical data could predict whether patients with schizophrenia have the side effect of QTc interval prolongation, which could fundamentally guide the choice of antipsychotic in patients with schizophrenia, especially for the first-episode patients.<\/jats:p>","DOI":"10.1038\/s41398-022-01825-0","type":"journal-article","created":{"date-parts":[[2022,2,8]],"date-time":"2022-02-08T08:03:57Z","timestamp":1644307437000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["ATAD3B and SKIL polymorphisms associated with antipsychotic-induced QTc interval change in patients with schizophrenia: a genome-wide association study"],"prefix":"10.1038","volume":"12","author":[{"given":"Zhe","family":"Lu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuyanan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0376-9037","authenticated-orcid":false,"given":"Hao","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4223-7551","authenticated-orcid":false,"given":"Liangkun","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yundan","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianlan","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9785-8489","authenticated-orcid":false,"given":"Hao","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lifang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6448-8568","authenticated-orcid":false,"given":"Jun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0833-246X","authenticated-orcid":false,"given":"Wenqiang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0358-0752","authenticated-orcid":false,"given":"Yongfeng","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3608-6208","authenticated-orcid":false,"given":"Xiao","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3963-660X","authenticated-orcid":false,"given":"Luxian","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3522-3912","authenticated-orcid":false,"given":"Yunlong","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dai","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1201-8465","authenticated-orcid":false,"given":"Weihua","family":"Yue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,2,8]]},"reference":[{"key":"1825_CR1","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/S0140-6736(15)01121-6","volume":"388","author":"MJ Owen","year":"2016","unstructured":"Owen MJ, Sawa A, Mortensen PB. Schizophrenia. Lancet. 2016;388:86\u201397.","journal-title":"Lancet"},{"key":"1825_CR2","doi-asserted-by":"publisher","first-page":"e04","DOI":"10.4088\/JCP.0207e04","volume":"68","author":"JA Lieberman","year":"2007","unstructured":"Lieberman JA. Effectiveness of antipsychotic drugs in patients with chronic schizophrenia: efficacy, safety and cost outcomes of CATIE and other trials. J Clin Psychiatry. 2007;68:e04.","journal-title":"J Clin Psychiatry"},{"key":"1825_CR3","doi-asserted-by":"publisher","first-page":"67","DOI":"10.3389\/fpsyt.2019.00067","volume":"10","author":"P Bozzatello","year":"2019","unstructured":"Bozzatello P, Bellino S, Rocca P. Predictive Factors of Treatment Resistance in First Episode of Psychosis: A Systematic Review. Front Psychiatry. 2019;10:67.","journal-title":"Front Psychiatry"},{"key":"1825_CR4","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.1056\/NEJMoa1915784","volume":"382","author":"NC Momen","year":"2020","unstructured":"Momen NC, Plana-Ripoll O, Agerbo E, Benros ME, B\u00f8rglum AD, Christensen MK, et al. Association between Mental Disorders and Subsequent Medical Conditions. N. Engl J Med. 2020;382:1721\u201331.","journal-title":"N. Engl J Med."},{"key":"1825_CR5","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1177\/2042098612454283","volume":"3","author":"S Nachimuthu","year":"2012","unstructured":"Nachimuthu S, Assar MD, Schussler JM. Drug-induced QT interval prolongation: mechanisms and clinical management. Therapeutic Adv Drug Saf. 2012;3:241\u201353.","journal-title":"Therapeutic Adv Drug Saf"},{"key":"1825_CR6","first-page":"687","volume":"108","author":"K Wenzel-Seifert","year":"2011","unstructured":"Wenzel-Seifert K, Wittmann M, Haen E. QTc prolongation by psychotropic drugs and the risk of Torsade de Pointes. Dtsch Arzteblatt Int. 2011;108:687\u201393.","journal-title":"Dtsch Arzteblatt Int"},{"key":"1825_CR7","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1016\/S0140-6736(19)31135-3","volume":"394","author":"M Huhn","year":"2019","unstructured":"Huhn M, Nikolakopoulou A, Schneider-Thoma J, Krause M, Samara M, Peter N, et al. Comparative efficacy and tolerability of 32 oral antipsychotics for the acute treatment of adults with multi-episode schizophrenia: a systematic review and network meta-analysis. Lancet (Lond, Engl). 2019;394:939\u201351.","journal-title":"Lancet (Lond, Engl)"},{"key":"1825_CR8","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1097\/YCO.0000000000000417","volume":"31","author":"CC Zai","year":"2018","unstructured":"Zai CC, Tiwari AK, Zai GC, Maes MS, Kennedy JL. New findings in pharmacogenetics of schizophrenia. Curr Opin Psychiatry. 2018;31:200\u201312.","journal-title":"Curr Opin Psychiatry"},{"key":"1825_CR9","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1038\/ng.3014","volume":"46","author":"DE Arking","year":"2014","unstructured":"Arking DE, Pulit SL, Crotti L, van der Harst P, Munroe PB, Koopmann TT, et al. Genetic association study of QT interval highlights role for calcium signaling pathways in myocardial repolarization. Nat Genet. 2014;46:826\u201336.","journal-title":"Nat Genet"},{"key":"1825_CR10","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1161\/CIRCULATIONAHA.120.045956","volume":"142","author":"N Lahrouchi","year":"2020","unstructured":"Lahrouchi N, Tadros R, Crotti L, Mizusawa Y, Postema PG, Beekman L, et al. Transethnic Genome-Wide Association Study Provides Insights in the Genetic Architecture and Heritability of Long QT Syndrome. Circulation. 2020;142:324\u201338.","journal-title":"Circulation."},{"key":"1825_CR11","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1038\/mp.2008.52","volume":"14","author":"S Volpi","year":"2009","unstructured":"Volpi S, Heaton C, Mack K, Hamilton JB, Lannan R, Wolfgang CD, et al. Whole genome association study identifies polymorphisms associated with QT prolongation during iloperidone treatment of schizophrenia. Mol Psychiatry. 2009;14:1024\u201331.","journal-title":"Mol Psychiatry"},{"key":"1825_CR12","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1038\/tpj.2010.76","volume":"12","author":"K Aberg","year":"2012","unstructured":"Aberg K, Adkins DE, Liu Y, McClay JL, Buksz\u00e1r J, Jia P, et al. Genome-wide association study of antipsychotic-induced QTc interval prolongation. Pharmacogenomics J. 2012;12:165\u201372.","journal-title":"Pharmacogenomics J"},{"key":"1825_CR13","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/S2215-0366(18)30049-X","volume":"5","author":"H Yu","year":"2018","unstructured":"Yu H, Yan H, Wang L, Li J, Tan L, Deng W, et al. Five novel loci associated with antipsychotic treatment response in patients with schizophrenia: a genome-wide association study. Lancet Psychiatry. 2018;5:327\u201338.","journal-title":"Lancet Psychiatry"},{"key":"1825_CR14","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1176\/appi.ajp.2019.1760501","volume":"177","author":"MC Funk","year":"2020","unstructured":"Funk MC, Beach SR, Bostwick JR, Celano C, Hasnain M, Pandurangi A, et al. QTc Prolongation and Psychotropic Medications. Am J Psychiatry. 2020;177:273\u20134.","journal-title":"Am J Psychiatry"},{"key":"1825_CR15","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1086\/519795","volume":"81","author":"S Purcell","year":"2007","unstructured":"Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MAR, Bender D, et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet. 2007;81:559\u201375.","journal-title":"Am J Hum Genet"},{"issue":"Suppl 1","key":"1825_CR16","doi-asserted-by":"publisher","first-page":"S90","DOI":"10.1093\/schbul\/sbv167","volume":"42","author":"S Leucht","year":"2016","unstructured":"Leucht S, Samara M, Heres S, Davis JM. Dose Equivalents for Antipsychotic Drugs: The DDD Method. Schizophrenia Bull. 2016;42(Suppl 1):S90\u20134.","journal-title":"Schizophrenia Bull"},{"key":"1825_CR17","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1038\/jhg.2016.72","volume":"61","author":"M Kanai","year":"2016","unstructured":"Kanai M, Tanaka T, Okada Y. Empirical estimation of genome-wide significance thresholds based on the 1000 Genomes Project data set. J Hum Genet. 2016;61:861\u20136.","journal-title":"J Hum Genet"},{"key":"1825_CR18","doi-asserted-by":"publisher","first-page":"1418","DOI":"10.1038\/nn.3801","volume":"17","author":"A Ramasamy","year":"2014","unstructured":"Ramasamy A, Trabzuni D, Guelfi S, Varghese V, Smith C, Walker R, et al. Genetic variability in the regulation of gene expression in ten regions of the human brain. Nat Neurosci. 2014;17:1418\u201328.","journal-title":"Nat Neurosci"},{"key":"1825_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-09234-6","volume":"10","author":"Y Zhou","year":"2019","unstructured":"Zhou Y, Zhou B, Pache L, Chang M, Khodabakhshi AH, Tanaseichuk O, et al. Metascape provides a biologist-oriented resource for the analysis of systems-level datasets. Nat Commun. 2019;10:1523.","journal-title":"Nat Commun"},{"key":"1825_CR20","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1038\/ejhg.2014.110","volume":"23","author":"M Hirokawa","year":"2015","unstructured":"Hirokawa M, Morita H, Tajima T, Takahashi A, Ashikawa K, Miya F, et al. A genome-wide association study identifies PLCL2 and AP3D1-DOT1L-SF3A2 as new susceptibility loci for myocardial infarction in Japanese. Eur J Hum Genet: EJHG. 2015;23:374\u201380.","journal-title":"Eur J Hum Genet: EJHG"},{"key":"1825_CR21","unstructured":"International Conference on Harmonisation; guidance on E14 Clinical Evaluation of QT\/QTc Interval Prolongation and Proarrhythmic Potential for Non-Antiarrhythmic Drugs; availability. Notice. Federal Register. 2005; 70:61134\u20135."},{"key":"1825_CR22","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1007\/s40263-014-0196-9","volume":"28","author":"M Hasnain","year":"2014","unstructured":"Hasnain M, Vieweg WVR. QTc interval prolongation and torsade de pointes associated with second-generation antipsychotics and antidepressants: a comprehensive review. CNS Drugs. 2014;28:887\u2013920.","journal-title":"CNS Drugs"},{"key":"1825_CR23","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1038\/nri.2017.21","volume":"17","author":"AP West","year":"2017","unstructured":"West AP, Shadel GS. Mitochondrial DNA in innate immune responses and inflammatory pathology. Nat Rev Immunol. 2017;17:363\u201375.","journal-title":"Nat Rev Immunol"},{"key":"1825_CR24","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1093\/brain\/awq320","volume":"134","author":"JP Kemp","year":"2011","unstructured":"Kemp JP, Smith PM, Pyle A, Neeve VCM, Tuppen HAL, Schara U, et al. Nuclear factors involved in mitochondrial translation cause a subgroup of combined respiratory chain deficiency. Brain: A J Neurol. 2011;134:183\u201395.","journal-title":"Brain: A J Neurol"},{"key":"1825_CR25","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1038\/nrg3275","volume":"13","author":"EA Schon","year":"2012","unstructured":"Schon EA, DiMauro S, Hirano M. Human mitochondrial DNA: roles of inherited and somatic mutations. Nat Rev Genet. 2012;13:878\u201390.","journal-title":"Nat Rev Genet"},{"key":"1825_CR26","doi-asserted-by":"publisher","first-page":"2539","DOI":"10.1093\/nar\/gkp100","volume":"37","author":"I Shokolenko","year":"2009","unstructured":"Shokolenko I, Venediktova N, Bochkareva A, Wilson GL, Alexeyev MF. Oxidative stress induces degradation of mitochondrial DNA. Nucleic Acids Res. 2009;37:2539\u201348.","journal-title":"Nucleic Acids Res"},{"key":"1825_CR27","doi-asserted-by":"crossref","unstructured":"Yan C, Duanmu X, Zeng L, Liu B, Song Z. Mitochondrial DNA: Distribution, Mutations, and Elimination. Cells. 2019;8:379.","DOI":"10.3390\/cells8040379"},{"key":"1825_CR28","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1038\/nrm3439","volume":"13","author":"L Kazak","year":"2012","unstructured":"Kazak L, Reyes A, Holt IJ. Minimizing the damage: repair pathways keep mitochondrial DNA intact. Nat Rev Mol Cell Biol. 2012;13:659\u201371.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"1825_CR29","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1038\/nrg1606","volume":"6","author":"RW Taylor","year":"2005","unstructured":"Taylor RW, Turnbull DM. Mitochondrial DNA mutations in human disease. Nat Rev Genet. 2005;6:389\u2013402.","journal-title":"Nat Rev Genet"},{"key":"1825_CR30","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/s10863-009-9211-0","volume":"41","author":"H Lemieux","year":"2009","unstructured":"Lemieux H, Hoppel CL. Mitochondria in the human heart. J Bioenerg Biomembranes. 2009;41:99\u2013106.","journal-title":"J Bioenerg Biomembranes"},{"key":"1825_CR31","doi-asserted-by":"publisher","first-page":"e00281","DOI":"10.1042\/BSR20150240","volume":"36","author":"M Wajner","year":"2015","unstructured":"Wajner M, Amaral AU. Mitochondrial dysfunction in fatty acid oxidation disorders: insights from human and animal studies. Biosci Rep. 2015;36:e00281.","journal-title":"Biosci Rep."},{"key":"1825_CR32","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1161\/01.CIR.91.4.955","volume":"91","author":"R Anan","year":"1995","unstructured":"Anan R, Nakagawa M, Miyata M, Higuchi I, Nakao S, Suehara M, et al. Cardiac involvement in mitochondrial diseases. A study on 17 patients with documented mitochondrial DNA defects. Circulation 1995;91:955\u201361.","journal-title":"Circulation"},{"key":"1825_CR33","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1007\/978-3-319-55330-6_5","volume":"982","author":"SR Lee","year":"2017","unstructured":"Lee SR, Han J. Mitochondrial Mutations in Cardiac Disorders. Adv Exp Med Biol. 2017;982:81\u2013111.","journal-title":"Adv Exp Med Biol"},{"key":"1825_CR34","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1093\/brain\/awx094","volume":"140","author":"R Desai","year":"2017","unstructured":"Desai R, Frazier AE, Durigon R, Patel H, Jones AW, Dalla Rosa I, et al. ATAD3 gene cluster deletions cause cerebellar dysfunction associated with altered mitochondrial DNA and cholesterol metabolism. Brain: A J Neurol. 2017;140:1595\u2013610.","journal-title":"Brain: A J Neurol"},{"key":"1825_CR35","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/j.ajhg.2020.01.007","volume":"106","author":"AC Gunning","year":"2020","unstructured":"Gunning AC, Strucinska K, Mu\u00f1oz Oreja M, Parrish A, Caswell R, Stals KL, et al. Recurrent De Novo NAHR Reciprocal Duplications in the ATAD3 Gene Cluster Cause a Neurogenetic Trait with Perturbed Cholesterol and Mitochondrial Metabolism. Am J Hum Genet. 2020;106:272\u20139.","journal-title":"Am J Hum Genet"},{"key":"1825_CR36","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1111\/brv.12373","volume":"93","author":"J Baudier","year":"2018","unstructured":"Baudier J. ATAD3 proteins: brokers of a mitochondria-endoplasmic reticulum connection in mammalian cells. Biol Rev Camb Philos Soc. 2018;93:827\u201344.","journal-title":"Biol Rev Camb Philos Soc"},{"key":"1825_CR37","doi-asserted-by":"publisher","first-page":"26764","DOI":"10.1074\/jbc.M112.386599","volume":"287","author":"AC Tecalco-Cruz","year":"2012","unstructured":"Tecalco-Cruz AC, Sosa-Garrocho M, V\u00e1zquez-Victorio G, Ortiz-Garc\u00eda L, Dom\u00ednguez-H\u00fcttinger E, Mac\u00edas-Silva M. Transforming growth factor-\u03b2\/SMAD Target gene SKIL is negatively regulated by the transcriptional cofactor complex SNON-SMAD4. J Biol Chem. 2012;287:26764\u201376.","journal-title":"J Biol Chem"},{"key":"1825_CR38","doi-asserted-by":"publisher","first-page":"3770","DOI":"10.1172\/JCI94753","volume":"127","author":"H Khalil","year":"2017","unstructured":"Khalil H, Kanisicak O, Prasad V, Correll RN, Fu X, Schips T, et al. Fibroblast-specific TGF-\u03b2-Smad2\/3 signaling underlies cardiac fibrosis. The. J Clin Investig. 2017;127:3770\u201383.","journal-title":"J Clin Investig"},{"key":"1825_CR39","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-31298-5","volume":"8","author":"F Extramiana","year":"2018","unstructured":"Extramiana F, Milleron O, Elbitar S, Uccellini A, Langeois M, Spentchian M, et al. High prevalence of ventricular repolarization abnormalities in people carrying TGF\u03b2R2 mutations. Sci Rep. 2018;8:13019.","journal-title":"Sci Rep"},{"key":"1825_CR40","doi-asserted-by":"publisher","first-page":"e0007602","DOI":"10.1371\/journal.pntd.0007602","volume":"13","author":"RR Ferreira","year":"2019","unstructured":"Ferreira RR, Abreu R, da S, Vilar-Pereira G, Degrave W, Meuser-Batista M, et al. TGF-\u03b2 inhibitor therapy decreases fibrosis and stimulates cardiac improvement in a pre-clinical study of chronic Chagas\u2019 heart disease. PLoS Neglected Tropical Dis. 2019;13:e0007602.","journal-title":"PLoS Neglected Tropical Dis"},{"key":"1825_CR41","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-33020-x","volume":"8","author":"JO Kim","year":"2018","unstructured":"Kim JO, Park JH, Kim T, Hong SE, Lee JY, Nho KJ, et al. A novel system-level approach using RNA-sequencing data identifies miR-30-5p and miR-142a-5p as key regulators of apoptosis in myocardial infarction. Sci Rep. 2018;8:14638.","journal-title":"Sci Rep."},{"key":"1825_CR42","doi-asserted-by":"publisher","first-page":"e60161","DOI":"10.1371\/journal.pone.0060161","volume":"8","author":"R Kishore","year":"2013","unstructured":"Kishore R, Verma SK, Mackie AR, Vaughan EE. Abramova T v, Aiko I, et al. Bone marrow progenitor cell therapy-mediated paracrine regulation of cardiac miRNA-155 modulates fibrotic response in diabetic hearts. PloS One. 2013;8:e60161.","journal-title":"PloS One"},{"key":"1825_CR43","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1093\/schbul\/sbv170","volume":"42","author":"Y Xu","year":"2016","unstructured":"Xu Y, Yue W, Yao Shugart Y, Li S, Cai L, Li Q, et al. Exploring Transcription Factors-microRNAs Co-regulation Networks in Schizophrenia. Schizophrenia Bull. 2016;42:1037\u201345.","journal-title":"Schizophrenia Bull"},{"key":"1825_CR44","doi-asserted-by":"publisher","first-page":"2786","DOI":"10.1038\/s41380-018-0206-2","volume":"25","author":"SE Yohn","year":"2020","unstructured":"Yohn SE, Foster DJ, Covey DP, Moehle MS, Galbraith J, Garcia-Barrantes PM, et al. Activation of the mGlu(1) metabotropic glutamate receptor has antipsychotic-like effects and is required for efficacy of M(4) muscarinic receptor allosteric modulators. Mol Psychiatry. 2020;25:2786\u201399.","journal-title":"Mol Psychiatry"},{"key":"1825_CR45","doi-asserted-by":"publisher","DOI":"10.1186\/s13148-020-00951-0","volume":"12","author":"SCE Maas","year":"2020","unstructured":"Maas SCE, Mens MMJ, K\u00fchnel B, van Meurs JBJ, Uitterlinden AG, Peters A, et al. Smoking-related changes in DNA methylation and gene expression are associated with cardio-metabolic traits. Clin Epigenetics. 2020;12:157.","journal-title":"Clin Epigenetics"},{"key":"1825_CR46","doi-asserted-by":"publisher","first-page":"e12719","DOI":"10.1111\/gbb.12719","volume":"20","author":"T Yamauchi","year":"2021","unstructured":"Yamauchi T, Kang G, Hiroi N. Heterozygosity of murine Crkl does not recapitulate behavioral dimensions of human 22q11.2 hemizygosity. Genes, Brain, Behav. 2021;20:e12719.","journal-title":"Genes, Brain, Behav"},{"key":"1825_CR47","doi-asserted-by":"publisher","first-page":"680819","DOI":"10.3389\/fcvm.2021.680819","volume":"8","author":"X Chen","year":"2021","unstructured":"Chen X, Barajas-Mart\u00ednez H, Xia H, Zhang Z, Chen G, Yang B, et al. Clinical and Functional Genetic Characterization of the Role of Cardiac Calcium Channel Variants in the Early Repolarization Syndrome. Front Cardiovascular Med. 2021;8:680819.","journal-title":"Front Cardiovascular Med"},{"key":"1825_CR48","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1093\/schbul\/sbz086","volume":"46","author":"CL Moody","year":"2020","unstructured":"Moody CL, Funk AJ, Devine E, Devore Homan RC, Boison D, McCullumsmith RE, et al. Adenosine Kinase Expression in the Frontal Cortex in Schizophrenia. Schizophrenia Bull. 2020;46:690\u20138.","journal-title":"Schizophrenia Bull"},{"key":"1825_CR49","doi-asserted-by":"publisher","first-page":"6272","DOI":"10.1128\/MCB.00472-06","volume":"26","author":"T-J Park","year":"2006","unstructured":"Park T-J, Boyd K, Curran T. Cardiovascular and craniofacial defects in Crk-null mice. Mol Cell Biol. 2006;26:6272\u201382.","journal-title":"Mol Cell Biol"},{"key":"1825_CR50","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1007\/s13238-020-00820-9","volume":"12","author":"D Liang","year":"2021","unstructured":"Liang D, Xue Z, Xue J, Xie D, Xiong K, Zhou H, et al. Sinoatrial node pacemaker cells share dominant biological properties with glutamatergic neurons. Protein Cell. 2021;12:545\u201356.","journal-title":"Protein Cell"},{"key":"1825_CR51","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1038\/s10038-020-00889-4","volume":"66","author":"S Yokotsuka-Ishida","year":"2021","unstructured":"Yokotsuka-Ishida S, Nakamura M, Tomiyasu Y, Nagai M, Kato Y, Tomiyasu A, et al. Positional cloning and comprehensive mutation analysis identified a novel KDM2B mutation in a Japanese family with minor malformations, intellectual disability, and schizophrenia. J Hum Genet. 2021;66:597\u2013606.","journal-title":"J Hum Genet"},{"key":"1825_CR52","doi-asserted-by":"crossref","unstructured":"Schizophrenia Working Group of the Psychiatric Genomics Consortium. Biological insights from 108 schizophrenia-associated genetic loci. Nature. 2014;511:421\u20137.","DOI":"10.1038\/nature13595"}],"container-title":["Translational Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41398-022-01825-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41398-022-01825-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41398-022-01825-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,23]],"date-time":"2022-11-23T19:06:25Z","timestamp":1669230385000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41398-022-01825-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,8]]},"references-count":52,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["1825"],"URL":"https:\/\/doi.org\/10.1038\/s41398-022-01825-0","relation":{},"ISSN":["2158-3188"],"issn-type":[{"value":"2158-3188","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,8]]},"assertion":[{"value":"14 October 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 January 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 January 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 February 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"56"}}